Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Delay J' OR with Authors including 'Delay J' OR with Abstract including 'Delay J' OR with Keywords including 'Delay J'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Delay J, Pichot P Diäthylamide de l'acide d-lysergique et troubles psychiques de l'ergot... C.r. Soc. Biol. 1951
Delay J, Lhermitte F, Ver... Modifications de l'électrocorticogramme du lapin par la diéthylamide d... Rev. Neurol. 1952
Delay J Etude de l'action du L.S.D.25 sur le lapin Eeg & Clin. Neurophy... 1953
Delay J, Pichot P, Laine ... Les modifications de la personnalité produites par la diéthylamide de ... Ann. med. psychol. 1954
Delay J, Thuillier J Psychiatrie expérimentale et psychoparmacologie Sem. hôp. 1956
Delay J, Thuillier J Dualité d'action du diéthylamide de l'acide lysergique sur la contract... Compt. rend. Soc. bi... 1956
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
Delay J, Pichot P, Lempér... Effets psycho-physiologiques de la Psilocybine Comptes rendus des s... 1958
Delay J, Benda P L'expérience lysergique. LSD-25. A propos de 75 observations cliniqu... Encéphale, Paris 1958
Delay J, Pichot P, Lempér... Étude psycho-physiologique et clinique de la Psilocybine Les champignons hall... 1958
Delay J, Pichot P, Lempér... La Psilocybine. I. Historique. Pharmacophysiologie. Clinique La Presse Médicale 1959
Delay J, Pichot P, Lempér... La Psilocybine. I. Historique. Pharmacophysiologie. Clinique, La Presse Médicale 1959
Delay J, Thuillier J, Nak... Action de la psilocybine sur le comportement des souris normales et de... Compt. Rend. Soc.de ... 1959
Orsini F, Benda P Etude expérimentale du ralentissement de la performance sous LSD-25. ... Ann.med.-psychol. 1959
Mahler DJ, Humoller FL Effect of lysergic acid diethylamide and bufotenine on performance of ... Proc. Soc. exper. Bi... 1959
Delay J, Pichot P, Lempér... Les effets somatiques de la Psilocybine Ann. Méd. Psychol. 1959
Delay J, Pichot P, Lempér... Les effets somatiques de la Psilocybine Presse méd. 1959
Delay J, Pichot P, Lempér... Les effets psychiques de la Psilocybine et les perspectives thérapeuti... Ann. Méd. Psychol. 1959
Delay J, Pichot P, Lempér... Les effets psychiques de la Psilocybine et les perspectives thérapeuti... Presse Méd. 1959
J Delay, P Pichot, T Lemp... Effet thérapeutique de la Psilocybine sur une névrose compulsive Ann. Méd. Psychol. 1959
J Delay, P Pichot, T Lemp... La Psilocybin. Actions psychologique et therapeutique. Presse med. 1959
Michaux H La Psilocybine (Experiences et Autocritique) Les Lettres Nouv. 1959
Delay J, Pichot P, Nicola... Premiers essais de la psilocybine en psychiatrie Neuro-Psychopharmaco... 1959
Quétin AM La Psilocybine en psychiatrie clinique et expérimentale Doctoral Thesis 1960
Gessner PK, Khairallah PA... The Relationship Between the Metabolic Fate and Pharmacological Action... J. Pharmacol. & Expe... 1960
Weintraub W, Silverstein ... The "correction" of deviant responses on a word association test A.M.A. Arch.Gen.Psyc... 1960
Delay J, Pichot P, Lempér... La Psilocybine. Ses Implications Thérapeutiques Le Sud Médical et Ch... 1961
Krill AE, Alpert HJ, Ostf... Effects of a hallucinogenic agent in totally blind subjects Arch. Ophthal. 1963
Delay J, Pichot P, Lempér... The therapeutic implications of psilocybine Hallucinogenic drugs... 1963
AISENBERG AC, WILES B Studies on the supression of immune responses by the periwinkle alkalo... J Clin Invest 1964
Bensoussan PA Les intoxications par les psycho-dysleptiques Les entretiens de Bi... 1967
Pérez De Francisco C Psicofarmacología y medicina Pren. Méd. Mex. 1970
Foote WE, Lieb JP, Martz ... Effect of hydrocortisone on single unit activity: in midbrain raphe. Brain Research 1972
Brown K, Cooper SJ Effects of lysergic acid diethylamide on auditory and visual discrimin... Brit J Pharmacol 1975
Halaris AE, Freedman DX, ... Plasma Corticoids And Brain Tryptophan After Acute And Tolerance Dosag... Life Sciences 1975
Bourgoin S, Artaud F, Enj... Acute Changes In Central Serotonin Metabolism Induced By The Blockade ... J. Pharmacol. exp. T... 1977
White FJ, Kuhn DM, Appel ... Discriminative Stimulus Properties of Quipazine Neuropharmacology 1977
Schlemmer RF, Heinze WJ, ... Evidence For Serotonin Mediation Of LSD-induced Abnormal Behavior In M... Federation Proc. 1979
Corrent G, McAdoo DJ, Esk... A Transmitter Role For Serotonin In The Aplysia Eye? Fed. Proc. 1979
Stern L In Vivo Assessment of the Teratogenic Potential of Drugs in Humans Obstetrics and Gynec... 1981
Snyder SH, Peroutka SJ A Possible Role of Serotonin Receptors in Antidepressant Drug Action Pharmacopsychiat. 1982
Strassman RJ Adverse reactions to psychedelic drugs. A review of the literature J Nerv Ment Dis 1984
Buffum J, Moser C MDMA and human sexual function J Psychoactive Drugs 1986
Krystal JH, Price LH, Ops... Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood ... Am J Drug Alcohol Ab... 1992
Nash JF, Yamamoto BK Methamphetamine neurotoxicity and striatal glutamate release: comparis... Brain Res 1992
Perez J, Burton BT, McGir... Airway compromise and delayed death following attempted central vein i... J Emerg Med 1994
Colado MI, Williams JL, G... The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 me... Br J Pharmacol 1995
White SR, Obradovic T, Im... The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on mono... Prog Neurobiol 1996
Moeller MR, Hartung M Ecstasy and Related Substances--Serum Levels in Impaired Drivers J Anal Toxicol 1997
Byard RW, Gilbert J, Jame... Amphetamine derivative fatalities in South Australia--is 'Ecstasy' the... Am J Forensic Med Pa... 1998
Bolla KI, McCann UD, Rica... Memory impairment in abstinent MDMA ('Ecstasy') users Neurology 1998
Dafters RI, Duffy F, O'Do... Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in... Psychopharmacology (... 1999
Marston HM, Reid ME, Lawr... Behavioural analysis of the acute and chronic effects of MDMA treatmen... Psychopharmacology (... 1999
Mintzer S, Hickenbottom S... Parkinsonism after taking ecstasy [Comment & Reply] N Engl J Med 1999
Rodgers J Cognitive performance amongst recreational users of 'ecstasy' Psychopharmacology (... 2000
Byrne T, Baker LE, Poling... MDMA and learning: effects of acute and neurotoxic exposure in the rat Pharmacol Biochem Be... 2000
Riba J, Rodri­guez-Fornel... Psychometric assessment of the Hallucinogen Rating Scale Drug Alcohol Depend 2001
Bhattachary S, Powell JH Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecsta... Psychol Med 2001
Zakzanis KK, Young DA Memory impairment in abstinent MDMA (“Ecstasy”) users: A longitudinal ... Neurology 2001
Zemishlany Z, Aizenberg D... Subjective effects of MDMA ('Ecstasy') on human sexual function Eur Psychiatry 2001
Reneman L, Lavalaye J, Sc... Cortical Serotonin Transporter Density and Verbal Memory in Individual... Archives of General ... 2001
Reneman L, Majoie CBLM, S... Pre-frontal N-acetylaspartate is strongly associated with memory perfo... Biological Psychiatr... 2001
Morley KC, Gallate JE, Hu... Increased anxiety and impaired memory in rats 3 months after administr... Eur J Pharmacol 2001
Jetter A, Kinzig-Schipper... Effects of grapefruit juice on the pharmacokinetics of sildenafil Clin Pharmacol Ther 2002
Grotenhermen F Pharmacokinetics and pharmacodynamics of cannabinoids Clin Pharmacokinet 2003
Yung AR, Phillips LJ, Yue... Psychosis prediction: 12-month follow up of a high-risk ('prodromal') ... Schizophr Res 2003
Zhou W, Cunningham KA, Th... Estrogen effects on the hyperactivity induced by (+)-MDMA and cocaine ... Behav Neurosci 2003
Zghoul T, Blier P Enhancing action of LSD on neuronal responsiveness to serotonin in a b... Int J Neuropsychopha... 2003
Curran HV, Verheyden SL Altered response to tryptophan supplementation after long-term abstent... Psychopharmacology (... 2003
Eckler JR, Chang-Fong J, ... Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabol... Pharmacol Biochem Be... 2003
Dafters RI, Hoshi R, Talb... Contribution of cannabis and MDMA ('ecstasy') to cognitive changes in ... Psychopharmacology (... 2003
Ho YJ, Pawlak CR, Guo L, ... Acute and long-term consequences of single MDMA administration in rela... Behav Brain Res 2004
Vupputuri S, Batuman V, M... The risk for mild kidney function decline associated with illicit drug... Am J Kidney Dis 2004
McCardle K, Luebbers S, C... Chronic MDMA (ecstasy) use, cognition and mood Psychopharmacology (... 2004
Vega WA, Gil AG Revisiting drug progression: long-range effects of early tobacco use Addiction 2005
Kuypers KP, Ramaekers JG Transient memory impairment after acute dose of 75mg 3.4-Methylene-dio... J Psychopharmacol 2005
Safarinejad MR, Hosseini ... Safety and efficacy of tramadol in the treatment of premature ejaculat... J Clin Psychopharmac... 2006
Williams MT, Herring NR, ... Alterations in Body Temperature, Corticosterone, and Behavior Followin... Neuropsychopharmacol... 2006
Schilt T, de Win MM, Koet... Cognition in novice ecstasy users with minimal exposure to other drugs... Arch Gen Psychiatry 2007
Capela JP, Macedo C, Bran... Neurotoxicity mechanisms of thioether ecstasy metabolites Neuroscience 2007
Chyka PA, Erdman AR, Mano... Dextromethorphan poisoning: an evidence-based consensus guideline for ... Clin Toxicol 2007
Marona-Lewicka D, Nichols... Further evidence that the delayed temporal dopaminergic effects of LSD... Pharmacol Biochem Be... 2007
Rogers G, Elston J, Garsi... The harmful health effects of recreational ecstasy: a systematic revie... Health Technol Asses... 2009
Linton KD, Wylie KR Recent advances in the treatment of premature ejaculation Drug Des Devel Ther 2010
Parrott AC Residual neurocognitive features of ecstasy use: a re-interpretation o... Addiction 2011
Coulson C, Caulkins JP Scheduling of Newly Emerging Drugs: A Critical Review of Decisions Ove... Addiction 2011
Puerta E, Barros-Miñones ... Long-lasting neuroprotective effect of sildenafil against 3,4-methylen... J Neurosci Res 2012
Goli V, Webster LR, Lamso... Effects of concurrent intravenous morphine sulfate and naltrexone hydr... Harm Reduct J 2012
Chary M, Genes N, McKenzi... Leveraging social networks for toxicovigilance J Med Toxicol 2013
Niciu MJ, Grunschel BD, C... Two cases of delayed-onset suicidal ideation, dysphoria and anxiety af... J Psychopharmacol 2013
Benzer TI, Nejad SH, Floo... Case records of the Massachusetts General Hospital Case 40-2013A 36-ye... N Engl J Med 2013
Litjens RP, Brunt TM How toxic is ibogaine? Clin Toxicol (Phila) 2016
Helander A, Bradley M, Ha... Acute skin and hair symptoms followed by severe, delayed eye complicat... Br J Dermatol 2016
Neto JC, Andrade AF, Lord... Preventing misidentification of 25I-NBOH as 2C-I on routine GC-MS anal... Forensic Toxicol 2017
Logan BK, Mohr ALA, Frisc... Reports of Adverse Events Associated with Use of Novel Psychoactive Su... J Anal Toxicol 2017
Heifets BD, Malenka RC Disruptive Psychopharmacology JAMA Psychiatry 2019